Xeris Biopharma Inc. (XERS)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

3.30

1.07%

Pre-market Dec 16, 2024, 07:13 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Revenue	163.91M	110.25M	110.25M	49.59M	20.16M	2.46M	1.56M	1.07M
Cost of Revenue	28.64M	22.63M	22.63M	13.32M	9.33M	42.00K	4.00K	8.00K
Gross Profit	135.27M	87.61M	87.61M	36.27M	10.83M	2.42M	1.55M	1.07M
Operating Income	-44.01M	-81.94M	-81.94M	-115.16M	-83.55M	-59.34M	-26.63M	-13.23M
Interest Income	4.75M	2.58M	2.58M	313.00K	2.96M	1.61M	124.00K	5.00K
Pretax Income	-63.50M	-96.08M	-96.08M	-122.72M	-91.25M	-60.08M	-26.55M	-13.21M
Net Income	-62.26M	-94.66M	-94.66M	-122.72M	-91.14M	-60.08M	-26.55M	-13.21M
Selling & General & Admin	146.09M	137.75M	137.75M	125.72M	73.73M	21.11M	8.02M	4.06M
Research & Development	22.34M	20.97M	20.97M	25.16M	20.92M	40.65M	20.17M	10.24M
Other Expenses	10.84M	-14.14M	10.84M	550.00K	-280.00K	-	-1K	-5.00K
Operating Expenses	168.44M	169.55M	169.55M	151.43M	94.37M	61.77M	28.18M	14.30M
Interest Expense	26.61M	15.32M	15.32M	7.18M	10.66M	2.54M	2.00K	2.00K
Selling & Marketing Expenses	-	-	-	-	-	-	-	-
Cost & Expenses	207.92M	192.19M	192.19M	164.75M	103.70M	61.81M	28.18M	14.31M
Income Tax	-1.25M	-1.42M	-1.42M	-110.00K	-110.00K	1.81M	1K	-3.00K
Shares Outstanding (Basic)	137.67M	135.63M	79.03M	42.64M	26.11M	12.05M	2.03M	1.84M
Shares Outstanding (Diluted)	137.67M	135.63M	79.03M	42.64M	26.11M	12.05M	2.03M	1.84M
EPS (Basic)	-0.45	-0.7	-1.2	-2.88	-3.49	-4.99	-13.09	-7.17
EPS (Diluted)	-0.45	-0.7	-1.2	-2.88	-3.49	-4.99	-13.09	-7.17
EBITDA	-23.73M	-69.31M	-113.67M	-80.08M	-117.80M	-57.22M	-26.38M	-13.09M
Depreciation & Amortization	13.16M	12.67M	1.88M	1.47M	1.08M	320.00K	177.00K	116.00K